Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Novartis AG

Symbol: NVS     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
3.18%
Current Price
$89.04
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 19:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
11,159,000,000
11,455,000,000
3,251,000,000
8,204,000,000
5,962,000,000
2,242,000,000
1,766,000,000
52,448,000,000
137,946,000,000
90,639,000,000
47,229,000,000
6,807,000,000
7,428,000,000
7,112,000,000
28,653,000,000
-6,442,000,000
2,412,000,000
 
2,299,000,000

Financials 2018

Update: 2019-06-09 19:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
13,269,000,000
13,664,000,000
4,926,000,000
8,738,000,000
7,439,000,000
1,299,000,000
1,195,000,000
35,563,000,000
145,563,000,000
66,871,000,000
78,614,000,000
13,271,000,000
9,678,000,000
15,964,000,000
32,148,000,000
-716,000,000
3,766,000,000
 
2,399,000,000

Q 3

2018-09-30
12,779,000,000
13,121,000,000
4,649,000,000
8,472,000,000
6,533,000,000
1,939,000,000
1,623,000,000
34,113,000,000
142,994,000,000
64,975,000,000
77,938,000,000
14,000,000,000
9,177,000,000
14,710,000,000
31,782,000,000
1,543,000,000
4,050,000,000
 
2,279,000,000

Q 2

2018-06-30
13,158,000,000
13,452,000,000
4,477,000,000
8,975,000,000
6,491,000,000
2,484,000,000
7,768,000,000
32,065,000,000
142,058,000,000
65,157,000,000
76,815,000,000
12,446,000,000
9,596,000,000
13,146,000,000
32,356,000,000
6,737,000,000
3,942,000,000
 
2,276,000,000

Q 1

2018-03-31
12,694,000,000
12,929,000,000
4,355,000,000
8,574,000,000
6,127,000,000
2,447,000,000
2,025,000,000
33,051,000,000
135,524,000,000
64,313,000,000
71,098,000,000
5,813,000,000
10,911,000,000
6,422,000,000
34,110,000,000
-3,127,000,000
2,514,000,000
 
2,120,000,000

Financials 2017

Update: 2019-06-09 19:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
12,915,000,000
13,164,000,000
4,489,000,000
8,675,000,000
6,605,000,000
2,070,000,000
1,976,000,000
28,208,000,000
133,079,000,000
58,852,000,000
74,168,000,000
8,860,000,000
5,308,000,000
9,485,000,000
28,532,000,000
16,000,000
3,408,000,000
 
2,502,000,000